Hi Guest
X
Real-Time Quote
Enter Company or MFGlenmark Pharmaceuticals Ltd. - Research Center
Results |
Quarterly
|
Statement | |
More |
(Rs crore)
Quarterly results in brief
| Sep ' 09 | Jun ' 09 | Mar ' 09 | Dec ' 08 | Sep ' 08 | |
|---|---|---|---|---|---|
| Sales | 236.10 | 220.10 | 191.38 | 244.55 | 226.03 |
| Operating profit | 62.81 | 6.40 | 18.97 | 79.50 | 76.08 |
| Interest | 7.42 | 1.98 | 5.47 | 24.24 | 15.93 |
| Gross profit | 58.01 | 6.30 | 77.20 | 64.62 | 85.49 |
| EPS (Rs) | 2.13 | 0.21 | 2.29 | 1.47 | 2.67 |
Quarterly results in details
| Sep ' 09 | Jun ' 09 | Mar ' 09 | Dec ' 08 | Sep ' 08 | |
|---|---|---|---|---|---|
| Other income | 2.62 | 1.88 | 63.70 | 9.37 | 25.34 |
| Stock adjustment | -14.73 | 3.51 | 2.36 | -11.48 | -3.81 |
| Raw material | 66.08 | 42.93 | 54.34 | 47.92 | 34.57 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 32.72 | 27.61 | 31.68 | 31.93 | 30.48 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 89.22 | 139.64 | 84.03 | 96.69 | 88.71 |
| Provisions made | - | - | - | - | - |
| Depreciation | 5.30 | 5.28 | 5.29 | 4.88 | 4.61 |
| Taxation | -4.79 | -4.21 | 14.62 | 22.82 | 13.99 |
| Net profit / loss | 57.50 | 5.22 | 57.28 | 36.92 | 66.89 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 26.96 | 25.06 | 25.05 | 25.05 | 25.02 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | 1390.86 | 1200.91 | 1200.24 | 1200.68 | 1197.83 |
| Agg.of non promotoholding (%) | 51.59 | 47.92 | 47.91 | 47.93 | 47.88 |
| OPM (%) | 26.60 | 2.91 | 9.91 | 32.51 | 33.66 |
| GPM (%) | 24.30 | 2.84 | 30.26 | 25.45 | 34.01 |
| NPM (%) | 24.09 | 2.35 | 22.46 | 14.54 | 26.61 |